Eclipse

What Eclipse does

Eclipse operates in the medical aesthetics industry and aligns with the Crown Aesthetics business unit of Revance (the entity formed by the merger of Crown Laboratories and Revance Therapeutics in 2025). The company sells an integrated portfolio of FDA-cleared aesthetic devices and skincare products to dermatologists, plastic surgeons, and medical aesthetic practices. Core devices include the SkinPen Precision Elite and MicroPen Evo microneedling systems, the latter indicated specifically for improvement of neck wrinkles (Fitzpatrick II-IV) and facial acne scars in adults aged 22 and older (Rx only), and the ProGen PRP system for point-of-care autologous platelet-rich plasma preparation. Skincare and ancillary aesthetic products include BIOJUVE, a topical line marketed as breakthrough skin science, plus Votesse. The portfolio is supported by FDA 510(k)-equivalent clearance (DEN160029) for SkinPen, CE Mark for European distribution, and ISO certification via the affiliated Bellus Medical entity.

Name

Eclipse

Legal name

Crown Aesthetics

Website

https://eclipsemed.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

11–50 employees

Short description

Eclipse operates in the medical aesthetics industry, marketing FDA-cleared microneedling devices (SkinPen, MicroPen Evo), PRP preparation systems (ProGen), and topical skincare (BIOJUVE) to dermatologists, plastic surgeons, and aesthetic practices globally as part of the Revance portfolio.

Ownership category

akta.pro rank

Product category

Medical Aesthetic Devices

NAICS

Medical Equipment and Supplies Manufacturing (3391)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Professional Skincare & Facial Treatments (CRABALAF)

akta.pro secondary industries

Dermocosmetics & Medical-Grade Skincare (CRABAAAF), Professional/Backbar Skincare (Esthetician & Spa Use) (CRABAAAK)

Keywords

• Aesthetic medical devices
• Microneedling systems
• Platelet-rich plasma systems
• Medical-grade skincare
• Aesthetic treatment devices

Headquarters

HQ city

Sanger

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Medical Device Sales: Sale of aesthetic medical devices including SkinPen Precision Elite microneedling systems and MicroPen Evo to aesthetic practices and medical professionals. These are capital equipment purchases for provider offices.
2. Consumables and Supplies: Ongoing sales of consumable products including PRP kits (ProGen), treatment serums, and skincare products (BIOJUVE) that providers purchase for use with their patients during procedures.
3. Provider Training and Education: Education and training programs for aesthetic providers on proper use of products, with events and certification programs.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Eclipse operates in the aesthetics industry, providing FDA-cleared medical aesthetic devices and skincare products to aesthetic medical practices. The portfolio includes microneedling systems (SkinPen Precision Elite, MicroPen Evo), platelet-rich plasma preparation systems (ProGen PRP), and topical skincare lines (BIOJUVE, Votesse). Products are sold exclusively through a network of certified aesthetic providers, dermatologists, and plastic surgeons for use in clinical patient treatments.

Product overview

Crown Aesthetics, a Revance Company, offers a comprehensive portfolio of aesthetic and skincare products. The product lineup includes SkinPen Precision Elite (microneedling device for wrinkle improvement and acne scar treatment), BIOJUVE (skincare product optimizing skin health), PROGEN PRP (platelet-rich plasma system), MicroPen Evo (microneedling device), and Votesse (aesthetic treatment). These products serve aesthetic practices and healthcare providers with rejuvenation and restoration solutions.

Differentiator

Problem solved

Functional benefit

Brands

• BIOJUVE: Breakthrough skin science that optimizes skin health on and below the surface.
• SkinPen Precision Elite
• ProGen PRP
• MicroPen Evo
• Votesse

Products and services

• SkinPen Precision Elite FDA-cleared microneedling device intended to improve the appearance of wrinkles of the neck for Fitzpatrick skin types II-IV and to improve the appearance of facial acne scars in adults with all Fitzpatrick skin types aged 22 years and older. Rx only. Internationally used for collagen induction therapy to treat melasma, acne, and surgical scars. Sold to aesthetic medical practices and providers.
• BIOJUVE Topical skincare product line based on breakthrough skin science that optimizes skin health on and below the surface. Sold through aesthetic medical practices for daily skincare maintenance offerings.
• ProGen PRP System Flexible Platelet-Rich Plasma system for rapid preparation of autologous PRP from a small sample of blood at the patient's point of care. Indicated for mixing with autograft/allograft bone prior to application to bony defects. Sold to medical practices for regenerative aesthetic procedures.
• MicroPen Evo Microneedling device for aesthetic treatments, designed for ease of use and implementation in clinical practice. Sold to aesthetic medical providers.
• Votesse Aesthetic treatment product in the Eclipse portfolio addressing domain-specific skin and aesthetic needs. Sold through certified aesthetic providers.

Quantifiable outcome

• SkinPen is indicated for improvement of facial acne scars in adults aged 22+ with all Fitzpatrick skin types and for wrinkles of the neck for Fitzpatrick types II-IV.

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• InMode: InMode is a publicly traded medical aesthetics company with a portfolio that includes Morpheus8 (RF microneedling), directly competing with SkinPen in the fractional/collagen-induction category and increasingly capturing share.
• BTL Aesthetics: BTL Aesthetics manufactures non-invasive body contouring, skin tightening, and feminine wellness devices sold to aesthetic practices; competes for the same capital equipment wallet of dermatologists and med-spas.
• Cutera: Cutera is an established medical aesthetics device company offering energy-based platforms (lasers, RF, microneedling with RF) sold to dermatologists and plastic surgeons; broader portfolio but overlaps with Crown Aesthetics at the aesthetic practice call point.
• Cynosure (Hologic): Cynosure is a global aesthetics device manufacturer offering laser, RF, and body-contouring platforms to medical spas and dermatology practices; competes broadly for the same capital equipment budget allocated by aesthetic providers.
• Galderma: Galderma is a global dermatology-focused company offering prescription aesthetics (Dysport, Restylane, Sculptra) and a therapeutic skincare line (Cetaphil, Alastin); overlaps with Crown Aesthetics on the dermatology call point and on medical-grade skincare adjacencies.
• Merz Aesthetics: Merz Aesthetics offers injectables (Xeomin, Radiesse, Belotero), devices (Ultherapy), and skincare (Neocutis); shares the same dermatologist and plastic surgeon customers and competes for the broader aesthetic treatment menu.

Direct peers

• Eclipse MedCorp: Eclipse MedCorp manufactures microneedling devices (Eclipse MicroPen) and PRP systems sold to medical aesthetics practices; directly competes with SkinPen Precision Elite, MicroPen Evo, and ProGen PRP on the same provider call points and the same clinical indications.
• Bellus Medical: Bellus Medical (acquired by Crown Laboratories) is a medical aesthetics company offering skin resurfacing devices and skincare products; directly overlaps with Crown Aesthetics' microneedling and skincare portfolio and shares the same provider network.

Emerging players

• EndyMed Medical: EndyMed Medical manufactures RF microneedling and skin rejuvenation devices for medical aesthetic practices; directly competes with SkinPen in the collagen induction therapy category with an energy-based modality.

Others

• Crown Laboratories: Crown Laboratories is the former parent of Crown Aesthetics and sister entity within Revance; operates in adjacent skincare and consumer health categories that overlap on distribution and brand assets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/Eclipsemed
• YouTubeyoutube.com/@CrownAesthetics
• Facebookfacebook.com/OneCrownAesthetics
• LinkedInlinkedin.com/company/crown-aesthetics
• Instagraminstagram.com/onecrownaesthetics

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eclipse